Efficacy of iloprost and montelukast combination on spinal cord ischemia/reperfusion injury in a rat model

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Lafci, Gokhan ^a   Gedik, Hikmet Selcuk ^b   Korkmaz, Kemal ^b   Erdem, Havva ^c   Cicek, Omer Faruk ^a   Nacar, Osman Arikan ^b   Yildirim, Levent ^b   Kaya, Ertugrul ^c   Ankarali, Handan ^c  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c DUZCE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875690445     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-64     Document Type: Article

References (32)

1. Svensson LG, Grawford ES, Hess KR, Coselli JS, Safi HJ. Experience with 1509 patients undergoing thoracoabdominal aortic operation. J Vasc Surg 1993, 17:357-70.
2. Wan IY, Angelini GD, Bryan AJ, Ryder I, Underwood MJ. Prevention of spinal cord ischemia during descending thoracoabdominal aortic surgery. Eur J Cardiothorac Surg 2001, 19:203-13. 10.1016/S1010-7940(00)00646-1, 11167113.
3. Crawford E, Crawford J, Safi H, Coselli J, Hess K, Brooks B. Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients. J Vasc Surg 1986, 3:389-404.
4. Zvara DA, Colonna DM, Deal DD, Vernon JC, Gowda M, Lundell JC. Ischemia preconditioning reduces neurologic injury in a rat model of spinal cord ischemia. Ann Thorac Surg 1999, 68:874-80. 10.1016/S0003-4975(99)00559-7, 10509977.
5. Martinez-Arizala A, Green B. Hypothermia in spinal cord injury. J Neurotrauma 1992, 9(Suppl 2):497-505.
6. Halici Z, Karaca M, Keles ON, Borekci B, Odabasoglu F, Suleyman H. Protective effects of amlodipine on ischemia-reperfusion injury of rat ovary: biochemical and histopathologic evaluation. Fertil Steril 2008, 90:2408-15. 10.1016/j.fertnstert.2007.10.007, 18178199.
7. Tator CH. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery 1998, 42:696-708. 10.1097/00006123-199804000-00007, 9574633.
8. Young W. The role of calcium in spinal cord injury. Cent Nerv Syst Trauma 1985, 2:109-114.
9. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 1993, 143(2):453-463. 1887029, 7688184.
10. Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians 1999, 111(5):383-9.
11. Choudhury S, Bae S, Ke Q, Lee JY, Kim J, Kang PM. Mitochondria to nucleus translocation of AIF in mice lacking Hsp70 during ischemia/reperfusion. Basic Res Cardiol 2011, 106(3):397-407. 10.1007/s00395-011-0164-1, 3205442, 21387140.
12. Saito T, Tsuchida M, Umehara S, Kohno T, Yamamoto H, Hayashi J. Reduction of Spinal Cord Ischemia/Reperfusion Injury with Simvastatin in Rats. Anesth Analg 2011, 113(3):565-71.
13. Cakir O, Erdem K, Oruc A, Kilinc N, Eren N. Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury. Cardiovasc Surg 2003, 11(5):375-9. 10.1016/S0967-2109(03)00077-2, 12958548.
14. Kalkan E, Keskin F, Kaya B, Esen H, Tosun M, Kalkan SS, Erdi F, Unlü A, Avunduk MC, Cicek O. Effects of iloprost and piracetam in spinal cord ischemia-reperfusion injury in the rabbit. Spinal Cord 2011, 49(1):81-6. 10.1038/sc.2010.76, 20585328.
15. Fantone JC, Marasco WA, Elgas LJ, Ward PA. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. Am J Pathol 1984, 115(1):9-16. 1900364, 6324595.
16. Yu GL, Wei EQ, Zhang SH, Xu HM, Chu LS, Zhang WP, Zhang Q, Chen Z, Mei RH, Zhao MH. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. Pharmacology 2005, 73:31-40. 10.1159/000081072, 15452361.
17. Mabe H, Nagai H, Suzuka T. Role of brain tissue leukotriene in brain edema following cerebral ischaemia: Effect of a 5-lipoxygenase inhibitor, AA-861. Neurol Res 1990, 12:165-168.
18. Rashmitha N, Sunder TJ, Srinivas CH, Srinivas N, Ray UK, Sharma HK. A validated RP-HPLC method for the determination ofimpurities in montelukast sodium. EJ Chem 2010, 7:555-63.
19. Taira Y, Marsala M. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Stroke 1996, 27:1850-8. 10.1161/01.STR.27.10.1850, 8841344.
20. Coselli JS, Le Maire SA, Poli De Figueiredo L, Kirby RP. Paraplegia after thoracoabdominal aortic aneurysm repair: is dissection a risk factor?. Ann Thorac Surg 1997, 63:28-36. 10.1016/S0003-4975(96)01029-6, 8993237.
21. Johnson SH, Kraimer JM, Graeber GM. Effects of flunarizine on neurological recovery and spinal cord blood flow in experimental spinal cord ischemia in 20 rabbits. Stroke 1993, 24:1547-1553. 10.1161/01.STR.24.10.1547, 8378960.
22. Crawford ES, Rubia PA. Reappraisal of adjuncts to avoid ischemia in the treatment of aneurysms of descending thoracic aorta. J Thorac Cardiovasc Surg 1973, 66:693-704.
23. Kanellopoulos GK, Kato H, Hsu CY, Kouchoukos NT. Spinal cord ischemic injury: Development of a new model in the rat. Stroke 1997, 28:2532-8. 10.1161/01.STR.28.12.2532, 9412645.
24. Lang-Lazdunski L, Heurteaux C, Mignon A, Mantz J, Widmann C, Desmonts J, Lazdunski M. Ischemic spinal cord injury induced by aortic cross-clamping:prevention by riluzole. Eur J Cardiothorac Surg 2000, 18(2):174-81. 10.1016/S1010-7940(00)00430-9, 10925226.
25. Smith PD, Puskas F, Meng X, Lee JH, Cleveland JC, Weyant MJ, Fullerton DA, Reece TB. The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury. Circulation 2012, 126:110-7.
26. Boga M, Discigil B, Ozkisacik EA, Gurcun U, Badak MI, Dikicioglu E, Yenisey C, Meteoglu I. The combined effect of iloprost and n-acetylcysteine in preventing spinal cord ischemia in rabbits. Eur J Vasc Endovasc Surg 2006, 31:366-72. 10.1016/j.ejvs.2005.10.027, 16359890.
27. Egemen N, Birler K, Avman N, Türker RK. Experimental cerebral vasospasm: resolution by iloprost. Acta Neurochir 1988, 95:131-5. 10.1007/BF01790774, 2465677.
28. Witt W, Muller B. Antithrombotic profile of iloprost in experimental models of in vivoplatelet aggregation and thrombosis. Adv Prostaglandin Thrombaxane Leukot Res 1987, 17:607-16.
29. Takamatsu H, Tsukada H, Watanabe Y, Cui Y, Kataoka Y, Hosoya T. Specific ligand for a central type prostacyclin receptor attenuates neuronal damage in a rat model of focal cerebral ischemia. Brain Res 2002, 925:176-82. 10.1016/S0006-8993(01)03280-2, 11792366.
30. Guo-Liang Y, Er-Qing W, Shi-Hong Z, Hui-Ming X, Li-Sheng C, Wei-Ping Z, Qi Zhang Z, Ru-Huan C, Mei Meng-Hui Z. Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, Dose- and Time-Dependently Protects against Focal Cerebral Ischemia in Mice. Pharmacology 2005, 73:31-40. 10.1159/000081072, 15452361.
31. Erşahin M, Çevik T, Akaki{dotless}n D, Şener A, Özbay L, Yegen BC, Şener G. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury. Prostaglandins Other Lipid Mediat 2012, 99:131-139. 10.1016/j.prostaglandins.2012.09.002, 22986158.
32. Genovese T, Rossi A, Mazzon E, Di Paola R, Muià C, Caminiti R, Bramanti P, Sautebin L, Cuzzocrea S. Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol 2008, 153:568-582. 10.1038/sj.bjp.0707577, 2241786, 18059327.